This website is intended for healthcare professionals only.

Newsletter          
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Pathology and diagnostics

T cell biomarker predicts CAR T cell therapy response in relapsed lymphoma
T cell biomarker predicts CAR T cell therapy response in relapsed lymphoma
Predictive model identifies factors linked to metformin failure in type 2 diabetics
Predictive model identifies factors linked to metformin failure in type 2 diabetics
Can procalcitonin levels determine which patients will benefit from azithromycin in lower RI? 
Can procalcitonin levels determine which patients will benefit from azithromycin in lower RI? 
Point-of-care test identifies bacterial and viral causes of acute respiratory infections
Point-of-care test identifies bacterial and viral causes of acute respiratory infections
Consensus group calls for routine use of cancer biomarkers and molecular profiling to guide precision medicine 
Consensus group calls for routine use of cancer biomarkers and molecular profiling to guide precision medicine 
Choroid plexus volume and permeability are potential MRI imaging markers for Alzheimer’s disease
Choroid plexus volume and permeability are potential MRI imaging markers for Alzheimer’s disease
Residual ctDNA predicts relapse in lung cancer
Residual ctDNA predicts relapse in lung cancer
Cardiac biomarkers offer no benefit to CV risk stratification in psoriasis disease
Cardiac biomarkers offer no benefit to CV risk stratification in psoriasis disease
Neurofilament light prognostic biomarker of choice for neurological outcomes after cardiac arrest
Neurofilament light prognostic biomarker of choice for neurological outcomes after cardiac arrest
Multi-organ point-of-care ultrasound useful for ruling out pulmonary embolism in COVID-19
Multi-organ point-of-care ultrasound useful for ruling out pulmonary embolism in COVID-19
MRI-guided thermoseed promising technique for brain tumour ablation
MRI-guided thermoseed promising technique for brain tumour ablation
NMR-based metabolomic biomarkers help identify cancer in patients with non-specific symptoms
NMR-based metabolomic biomarkers help identify cancer in patients with non-specific symptoms


Popular articles

Ketogenic diet linked to higher LDL cholesterol and increased risk of adverse cardiac events
Both controlled and uncontrolled hypertension in obese patients increase all-cause mortality risk
Shorter tuberculosis treatment strategy non-inferior to standard regimen
Prostate cancer mortality no different in trial of three treatment interventions
Zavegepant nasal spray approved for acute migraine




 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora